This inventor holds 1 USPTO granted patent. Top assignee: Zenyaku Kogyo Kabushiki Kaisha. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Hiroto Kawashima: Innovator in Anti-Malignant Tumor Agents
Introduction
Hiroto Kawashima is an esteemed inventor residing in Shizuoka-ken, Japan. With a focus on groundbreaking advancements in the field of pharmaceuticals, Kawashima has made significant contributions, particularly in the development of heterocyclic compounds that serve as active ingredients in anti-malignant tumor agents. His innovative work showcases a deep commitment to improving cancer treatment.
Latest Patents
Hiroto Kawashima holds a notable patent for a heterocyclic compound characterized by a formula that represents its unique structure and function. This patent, titled "Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient," includes a description of the compound's composition, which allows for effective anti-cancer properties. The patent details components such as nitrogen atoms, C-alkyl groups, and morpholino structures, indicating a sophisticated understanding of medicinal chemistry.
Career Highlights
Kawashima's career is marked by his role at Zenyaku Kogyo Kabushiki Kaisha, an innovative company dedicated to pharmaceutical advancements. His work has led to advancements in cancer therapies, positioning him as a key figure in the fight against malignancies. Through his patent, he actively contributes to the field of oncology and supports ongoing research into new treatments.
Collaborations
In his endeavors, Hiroto collaborates with talented individuals such as Seiichiro Kawashima and Mitsuko Kawashima, who serve as legal representatives in his field. Their collective expertise not only enhances the research and development processes but also fosters a collaborative environment crucial for innovation in pharmaceutical science.
Conclusion
Hiroto Kawashima stands out as a significant contributor to the field of anti-malignant tumor research. His patent, focused on heterocyclic compounds, reflects his dedication to advancing cancer treatment. With ongoing collaborations and a robust career at Zenyaku Kogyo Kabushiki Kaisha, Kawashima's work continues to inspire future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile